United States Biotechnology & Medical Research

Oncorus Inc (ONCR)

Track

Ticker: ONCR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Flynn James E
3 sales — total 37,495 USD
Sale 30 Dec 2022
Value US$1,207,184.48 | Price 290.35 | Shares 71,549
Sale 30 Dec 2022
Value US$3,086,855.29 | Price 81.88 | Shares 27,429
Sale 30 Dec 2022
Value US$16,693.02 | Price 0.27 | Shares 61,826
Sale 29 Dec 2022
Value US$4,778,188.37 | Price 58.20 | Shares 48,376
Sale 29 Dec 2022
Value US$3,671,330.30 | Price 159.58 | Shares 23,042
Sale 29 Dec 2022
Value US$16,407.82 | Price 0.26 | Shares 63,107
Sale 28 Dec 2022
Value US$1,524.00 | Price 0.25 | Shares 6,096
Sale 28 Dec 2022
Value US$6,189.25 | Price 0.25 | Shares 24,757
Sale 28 Dec 2022
Value US$6,189.25 | Price 0.25 | Shares 24,757
Sale 27 Dec 2022
Value US$1,926.72 | Price 0.27 | Shares 7,136
Sale 27 Dec 2022
Value US$7,823.79 | Price 0.27 | Shares 28,977
Sale 27 Dec 2022
Value US$7,823.79 | Price 0.27 | Shares 28,977
Sale 22 Dec 2022
Value US$254.52 | Price 0.28 | Shares 909
Sale 22 Dec 2022
Value US$1,034.04 | Price 0.28 | Shares 3,693
Sale 22 Dec 2022
Value US$1,033.76 | Price 0.28 | Shares 3,692
Sale 21 Dec 2022
Value US$453.90 | Price 0.30 | Shares 1,513
Sale 21 Dec 2022
Value US$1,842.90 | Price 0.30 | Shares 6,143
Sale 21 Dec 2022
Value US$1,843.20 | Price 0.30 | Shares 6,144
Sale 20 Dec 2022
Value US$500.96 | Price 0.31 | Shares 1,616
Sale 20 Dec 2022
Value US$2,034.22 | Price 0.31 | Shares 6,562
Sale 20 Dec 2022
Value US$2,034.22 | Price 0.31 | Shares 6,562
Sale 19 Dec 2022
Value US$3,169.70 | Price 0.29 | Shares 10,930
Sale 19 Dec 2022
Value US$12,874.26 | Price 0.29 | Shares 44,394
Sale 19 Dec 2022
Value US$12,874.26 | Price 0.29 | Shares 44,394
Sale 15 Dec 2022
Value US$132.21 | Price 0.39 | Shares 339
Sale 15 Dec 2022
Value US$536.25 | Price 0.39 | Shares 1,375
Sale 15 Dec 2022
Value US$536.25 | Price 0.39 | Shares 1,375
Sale 14 Dec 2022
Value US$358.34 | Price 0.38 | Shares 943
Sale 14 Dec 2022
Value US$1,455.02 | Price 0.38 | Shares 3,829
Sale 14 Dec 2022
Value US$1,454.64 | Price 0.38 | Shares 3,828
Sale 13 Dec 2022
Value US$94.30 | Price 0.41 | Shares 230
Sale 13 Dec 2022
Value US$382.53 | Price 0.41 | Shares 933
Sale 13 Dec 2022
Value US$382.94 | Price 0.41 | Shares 934
Buy 25 May 2022
Value US$4,532.40 | Price 1.20 | Shares 3,777
Buy 20 May 2022
Value US$1,932.00 | Price 1.20 | Shares 1,610
Buy 19 May 2022
Value US$6,450.00 | Price 1.29 | Shares 5,000
Buy 17 May 2022
Value US$1.20 | Price 1.20 | Shares 1
Buy 16 May 2022
Value US$24,331.60 | Price 1.18 | Shares 20,620
Buy 13 May 2022
Value US$4,482.70 | Price 1.15 | Shares 3,898
Buy 12 May 2022
Value US$15,221.52 | Price 1.08 | Shares 14,094
Buy 16 Nov 2021
Value US$86,700.00 | Price 5.78 | Shares 15,000
Buy 16 Nov 2021
Value US$86,955.00 | Price 5.80 | Shares 15,000
Planned sale 2 Jun 2021
Value US$177,528.96 | Price 16.66 | Shares 10,656
Planned sale 1 Jun 2021
Value US$215,284.31 | Price 16.69 | Shares 12,899
Planned sale 30 Apr 2021
Value US$13,408.00 | Price 16.76 | Shares 800
Planned sale 30 Apr 2021
Value US$362,714.70 | Price 15.94 | Shares 22,755
Planned sale 6 Apr 2021
Value US$79,553.00 | Price 15.01 | Shares 5,300
Buy 17 Feb 2021
Value US$624,796.00 | Price 19.00 | Shares 32,884
Buy 17 Feb 2021
Value US$2,537,602.00 | Price 19.00 | Shares 133,558
Buy 17 Feb 2021
Value US$2,537,602.00 | Price 19.00 | Shares 133,558
Buy 6 Oct 2020
Value US$2,268,360.00 | Price 15.00 | Shares 151,224
Buy 6 Oct 2020
Value US$2,268,360.00 | Price 15.00 | Shares 151,224
Buy 6 Oct 2020
Value US$2,606,640.00 | Price 15.00 | Shares 173,776
Buy 6 Oct 2020
Value US$2,268,375.00 | Price 15.00 | Shares 151,225
Buy 6 Oct 2020
Value US$2,606,640.00 | Price 15.00 | Shares 173,776
Buy 6 Oct 2020
Value US$2,606,640.00 | Price 15.00 | Shares 173,776
Buy 6 Oct 2020
Value US$1,644,180.00 | Price 15.00 | Shares 109,612
Buy 6 Oct 2020
Value US$6,677,910.00 | Price 15.00 | Shares 445,194
Buy 6 Oct 2020
Value US$6,677,910.00 | Price 15.00 | Shares 445,194
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-30 2022-12-30 S Sale
2.8
Flynn James E
Large shareholder
71,549 +10.1%
290.35
US$1,207,184 		71,549 +10.1% 290.35 US$1,207,184
2022-12-30 2022-12-30 S Sale
2.8
Flynn James E
Large shareholder
27,429 -34.7%
81.88
US$3,086,855 		27,429 -34.7% 81.88 US$3,086,855
2022-12-30 2022-12-30 S Sale
2.8
Flynn James E
Large shareholder
63,680 +18.6%
357.26
US$4,658,033 		63,680 +18.6% 357.26 US$4,658,033
2022-12-30 2022-12-29 S Sale
2.8
Flynn James E
Large shareholder
15,538 -4.9%
0.26
US$4,040 		15,538 -4.9% 0.26 US$4,040
2022-12-30 2022-12-29 S Sale
2.8
Flynn James E
Large shareholder
63,108 -4.9%
0.26
US$16,408 		63,108 -4.9% 0.26 US$16,408
2022-12-30 2022-12-29 S Sale
2.8
Flynn James E
Large shareholder
63,107 -4.9%
0.26
US$16,408 		63,107 -4.9% 0.26 US$16,408
2022-12-30 2022-12-28 S Sale
2.8
Flynn James E
Large shareholder
6,096 -1.9%
0.25
US$1,524 		6,096 -1.9% 0.25 US$1,524
2022-12-30 2022-12-28 S Sale
2.8
Flynn James E
Large shareholder
24,757 -1.9%
0.25
US$6,189 		24,757 -1.9% 0.25 US$6,189
2022-12-30 2022-12-28 S Sale
2.8
Flynn James E
Large shareholder
24,757 -1.9%
0.25
US$6,189 		24,757 -1.9% 0.25 US$6,189
2022-12-27 2022-12-27 S Sale
2.8
Flynn James E
Large shareholder
7,136 -2.2%
0.27
US$1,927 		7,136 -2.2% 0.27 US$1,927
2022-12-27 2022-12-27 S Sale
2.8
Flynn James E
Large shareholder
28,977 -2.2%
0.27
US$7,824 		28,977 -2.2% 0.27 US$7,824
2022-12-27 2022-12-27 S Sale
2.8
Flynn James E
Large shareholder
28,977 -2.2%
0.27
US$7,824 		28,977 -2.2% 0.27 US$7,824
2022-12-27 2022-12-22 S Sale
2.8
Flynn James E
Large shareholder
909 -0.3%
0.28
US$255 		909 -0.3% 0.28 US$255
2022-12-27 2022-12-22 S Sale
2.8
Flynn James E
Large shareholder
3,693 -0.3%
0.28
US$1,034 		3,693 -0.3% 0.28 US$1,034
2022-12-27 2022-12-22 S Sale
2.8
Flynn James E
Large shareholder
3,692 -0.3%
0.28
US$1,034 		3,692 -0.3% 0.28 US$1,034
2022-12-21 2022-12-21 S Sale
2.8
Flynn James E
Large shareholder
1,513 -0.5%
0.30
US$454 		1,513 -0.5% 0.30 US$454
2022-12-21 2022-12-21 S Sale
2.8
Flynn James E
Large shareholder
6,143 -0.5%
0.30
US$1,843 		6,143 -0.5% 0.30 US$1,843
2022-12-21 2022-12-21 S Sale
2.8
Flynn James E
Large shareholder
6,144 -0.5%
0.30
US$1,843 		6,144 -0.5% 0.30 US$1,843
2022-12-21 2022-12-20 S Sale
2.8
Flynn James E
Large shareholder
1,616 -0.5%
0.31
US$501 		1,616 -0.5% 0.31 US$501
2022-12-21 2022-12-20 S Sale
2.8
Flynn James E
Large shareholder
6,562 -0.5%
0.31
US$2,034 		6,562 -0.5% 0.31 US$2,034
2022-12-21 2022-12-20 S Sale
2.8
Flynn James E
Large shareholder
6,562 -0.5%
0.31
US$2,034 		6,562 -0.5% 0.31 US$2,034
2022-12-21 2022-12-19 S Sale
2.8
Flynn James E
Large shareholder
10,930 -3.2%
0.29
US$3,170 		10,930 -3.2% 0.29 US$3,170
2022-12-21 2022-12-19 S Sale
2.8
Flynn James E
Large shareholder
44,394 -3.2%
0.29
US$12,874 		44,394 -3.2% 0.29 US$12,874
2022-12-21 2022-12-19 S Sale
2.8
Flynn James E
Large shareholder
44,394 -3.2%
0.29
US$12,874 		44,394 -3.2% 0.29 US$12,874
2022-12-15 2022-12-15 S Sale
2.8
Flynn James E
Large shareholder
339 -0.1%
0.39
US$132 		339 -0.1% 0.39 US$132
2022-12-15 2022-12-15 S Sale
2.8
Flynn James E
Large shareholder
1,375 -0.1%
0.39
US$536 		1,375 -0.1% 0.39 US$536
2022-12-15 2022-12-15 S Sale
2.8
Flynn James E
Large shareholder
1,375 -0.1%
0.39
US$536 		1,375 -0.1% 0.39 US$536
2022-12-15 2022-12-14 S Sale
2.8
Flynn James E
Large shareholder
943 -0.3%
0.38
US$358 		943 -0.3% 0.38 US$358
2022-12-15 2022-12-14 S Sale
2.8
Flynn James E
Large shareholder
3,829 -0.3%
0.38
US$1,455 		3,829 -0.3% 0.38 US$1,455
2022-12-15 2022-12-14 S Sale
2.8
Flynn James E
Large shareholder
3,828 -0.3%
0.38
US$1,455 		3,828 -0.3% 0.38 US$1,455
2022-12-15 2022-12-13 S Sale
2.8
Flynn James E
Large shareholder
230 -0.1%
0.41
US$94 		230 -0.1% 0.41 US$94
2022-12-15 2022-12-13 S Sale
2.8
Flynn James E
Large shareholder
933 -0.1%
0.41
US$383 		933 -0.1% 0.41 US$383
2022-12-15 2022-12-13 S Sale
2.8
Flynn James E
Large shareholder
934 -0.1%
0.41
US$383 		934 -0.1% 0.41 US$383
2022-05-25 2022-05-25 B Purchase
Wanstall Rick

CFO and Treasurer

Officer
3,777 +8.0%
1.20
US$4,532 		3,777 +8.0% 1.20 US$4,532
2022-05-24 2022-05-20 B Purchase
Wanstall Rick

CFO and Treasurer

Officer
1,610 +3.5%
1.20
US$1,932 		1,610 +3.5% 1.20 US$1,932
2022-05-19 2022-05-19 B Purchase
Wanstall Rick

CFO and Treasurer

Officer
5,000 +12.3%
1.29
US$6,450 		5,000 +12.3% 1.29 US$6,450
2022-05-19 2022-05-17 B Purchase
Wanstall Rick

CFO and Treasurer

Officer
1
1.20
US$1 		1 1.20 US$1
2022-05-16 2022-05-16 B Purchase
Wanstall Rick

CFO and Treasurer

Officer
20,620 +103.1%
1.18
US$24,332 		20,620 +103.1% 1.18 US$24,332
2022-05-16 2022-05-13 B Purchase
Wanstall Rick

CFO and Treasurer

Officer
3,898 +24.2%
1.15
US$4,483 		3,898 +24.2% 1.15 US$4,483
2022-05-16 2022-05-12 B Purchase
Wanstall Rick

CFO and Treasurer

Officer
14,094 +704.7%
1.08
US$15,222 		14,094 +704.7% 1.08 US$15,222
2021-11-17 2021-11-16 B Purchase
Harbin Stephen

COO and Chief of Staff

Officer
15,000 +inf%
5.78
US$86,700 		15,000 +inf% 5.78 US$86,700
2021-11-17 2021-11-16 B Purchase
Harbin Stephen

COO and Chief of Staff

Officer
15,000 +inf%
5.80
US$86,955 		15,000 +inf% 5.80 US$86,955
2021-06-03 2021-06-02 PlS Planned sale
Queva Christophe

CSO and SVP, Research

Officer
10,656 -18.3%
16.66
US$177,529 		10,656 -18.3% 16.66 US$177,529
2021-06-03 2021-06-01 PlS Planned sale
Queva Christophe

CSO and SVP, Research

Officer
12,899 -18.1%
16.69
US$215,284 		12,899 -18.1% 16.69 US$215,284
2021-05-04 2021-04-30 PlS Planned sale
Queva Christophe

CSO and SVP, Research

Officer
800 -2.2%
16.76
US$13,408 		800 -2.2% 16.76 US$13,408
2021-05-04 2021-04-30 PlS Planned sale
Queva Christophe

CSO and SVP, Research

Officer
22,755 -38.5%
15.94
US$362,715 		22,755 -38.5% 15.94 US$362,715
2021-04-08 2021-04-06 PlS Planned sale
Queva Christophe

CSO and SVP, Research

Officer
5,300 -6.4%
15.01
US$79,553 		5,300 -6.4% 15.01 US$79,553
2021-02-18 2021-02-17 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
32,884 +10.5%
19.00
US$624,796 		32,884 +10.5% 19.00 US$624,796
2021-02-18 2021-02-17 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
133,558 +10.5%
19.00
US$2,537,602 		133,558 +10.5% 19.00 US$2,537,602
2021-02-18 2021-02-17 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
133,558 +10.5%
19.00
US$2,537,602 		133,558 +10.5% 19.00 US$2,537,602
2020-10-08 2020-10-06 B Purchase
2.3
UBS Oncology Impact Fund L.P.
Large shareholder
151,224 +6.8%
15.00
US$2,268,360 		151,224 +6.8% 15.00 US$2,268,360
2020-10-08 2020-10-06 B Purchase
3.1
GADICKE ANSBERT
Large shareholder
151,224 +6.8%
15.00
US$2,268,360 		151,224 +6.8% 15.00 US$2,268,360
2020-10-08 2020-10-06 B Purchase
3.1
GADICKE ANSBERT
Large shareholder
173,776 +6.5%
15.00
US$2,606,640 		173,776 +6.5% 15.00 US$2,606,640
2020-10-08 2020-10-06 B Purchase
1.8
EVNIN LUKE
Non-Executive Director Large shareholder
151,225 +6.5%
15.00
US$2,268,375 		151,225 +6.5% 15.00 US$2,268,375
2020-10-08 2020-10-06 B Purchase
2.4
MPM SunStates Fund, L.P.
Large shareholder
173,776 +6.5%
15.00
US$2,606,640 		173,776 +6.5% 15.00 US$2,606,640
2020-10-08 2020-10-06 B Purchase
3.2
MPM BioVentures 2014, L.P.
Large shareholder
173,776 +6.5%
15.00
US$2,606,640 		173,776 +6.5% 15.00 US$2,606,640
2020-10-08 2020-10-06 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
109,612 +54.1%
15.00
US$1,644,180 		109,612 +54.1% 15.00 US$1,644,180
2020-10-08 2020-10-06 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
445,194 +54.1%
15.00
US$6,677,910 		445,194 +54.1% 15.00 US$6,677,910
2020-10-08 2020-10-06 B Purchase
2.8
Flynn James E
Non-Executive Director Large shareholder
445,194 +54.1%
15.00
US$6,677,910 		445,194 +54.1% 15.00 US$6,677,910
Explore more

More insider trading research around Oncorus Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America